Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
994.88
1,150.45
1,191.92
1,113.69
1,021.28
837.58
1,108.89
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
994.88
1,150.45
1,191.92
1,113.69
1,021.28
837.58
1,108.89
Raw Material Cost
726.02
857.23
881.93
806.62
719.94
538.02
827.03
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
126.39
139.32
142.55
165.74
170.19
166.97
138.36
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
15.23
14.40
12.73
14.29
14.20
17.04
17.56
Selling and Distribution Expenses
190.07
208.46
225.08
221.53
220.31
262.48
231.79
Other Expenses
-11.80
-13.46
-13.45
-16.20
-16.82
-16.91
-13.88
Total Expenditure (Excl Depreciation)
939.73
1,084.76
1,127.82
1,046.20
956.41
815.39
1,075.91
Operating Profit (PBDIT) excl Other Income
55.199999999999996
65.7
64.1
67.5
64.9
22.200000000000003
33
Other Income
9.35
30.18
29.68
21.22
14.55
51.81
53.94
Operating Profit (PBDIT)
92.69
117.71
115.96
133.12
121.34
112.81
128.09
Interest
15.23
14.40
12.73
14.29
14.20
17.04
17.56
Exceptional Items
4.00
1.39
13.20
-4.71
7.63
8.76
0.11
Gross Profit (PBDT)
268.86
293.22
309.99
307.07
301.34
299.56
281.86
Depreciation
28.19
21.85
22.18
44.41
41.92
38.81
41.18
Profit Before Tax
53.27
82.86
94.24
69.71
72.85
65.72
69.46
Tax
20.11
22.83
35.68
27.96
21.96
22.48
22.15
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
12.24
45.06
42.10
26.45
36.54
13.17
49.24
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
12.24
45.06
42.10
26.45
36.54
13.17
49.24
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
29.94
35.68
25.97
24.19
25.18
44.02
7.76
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
42.18
80.74
68.06
50.63
61.72
57.18
57.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.12
0.12
0.0
Reserves
688.00
680.87
681.56
691.13
754.63
701.67
674.90
Earnings per share (EPS)
0.02
0.08
0.07
0.04
0.06
0.02
0.08
Diluted Earnings per share
0.02
0.08
0.07
0.04
0.06
0.02
0.08
Operating Profit Margin (Excl OI)
5.54%
5.71%
5.38%
6.06%
6.35%
2.65%
2.97%
Gross Profit Margin
8.19%
9.1%
9.77%
10.25%
11.24%
12.48%
9.98%
PAT Margin
1.23%
3.92%
3.53%
2.37%
3.58%
1.57%
4.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -13.52% vs -3.47% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -47.71% vs 18.50% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -4.80% vs 1.39% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 5.56% vs 13.39% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Kingworld Medicines Group Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
994.88
38.94
955.94
2,454.90%
Other Operating Income
0.00
0.00
0.00
Total Operating income
994.88
38.94
955.94
2,454.90%
Raw Material Cost
726.02
29.71
696.31
2,343.69%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
126.39
15.56
110.83
712.28%
Power Cost
0
0
0.00
Manufacturing Expenses
15.23
0.25
14.98
5,992.00%
Selling and Distribution Expenses
190.07
49.27
140.80
285.77%
Other Expenses
-11.80
-1.58
-10.22
-646.84%
Total Expenditure (Excl Depreciation)
939.73
78.98
860.75
1,089.83%
Operating Profit (PBDIT) excl Other Income
55.15
-40.04
95.19
237.74%
Other Income
9.35
0.40
8.95
2,237.50%
Operating Profit (PBDIT)
92.69
-36.23
128.92
355.84%
Interest
15.23
0.25
14.98
5,992.00%
Exceptional Items
4.00
-27.48
31.48
114.56%
Gross Profit (PBDT)
268.86
9.23
259.63
2,812.89%
Depreciation
28.19
3.41
24.78
726.69%
Profit Before Tax
53.27
-67.38
120.65
179.06%
Tax
20.11
0.44
19.67
4,470.45%
Provisions and contingencies
0
0
0.00
Profit After Tax
12.24
-67.79
80.03
118.06%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
12.24
-67.79
80.03
118.06%
Share in Profit of Associates
0
0
0.00
Minority Interest
29.94
-0.03
29.97
99,900.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
42.18
-67.82
110.00
162.19%
Equity Capital
0
0
0.00
Face Value
0.00
0.10
0.00
Reserves
688.00
-7.66
695.66
9,081.72%
Earnings per share (EPS)
0.02
-0.11
0.13
118.18%
Diluted Earnings per share
0.02
-0.11
0.13
118.18%
Operating Profit Margin (Excl OI)
5.54%
-102.81%
0.00
108.35%
Gross Profit Margin
8.19%
-164.26%
0.00
172.45%
PAT Margin
1.23%
-174.07%
0.00
175.30%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 99.49 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -13.52% vs -3.47% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 4.22 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -47.71% vs 18.50% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.33 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -4.80% vs 1.39% in Dec 2024
Annual - Interest
Interest 1.52 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 5.56% vs 13.39% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.54%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






